Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

ERYTHROMYCIN

ERYTHROMYCIN

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 064067 (ANDA).

Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength OINTMENT;OPHTHALMIC - 0.5% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2002-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN is listed in Drugs@FDA under application 064067 (ANDA). Marketing status: Prescription Active ingredient ERYTHROMYCIN Form and strength OINTMENT;OPHTHALMIC - 0.5% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2002-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: UNKNOWN
  • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.